drugset / Trial / NCT07690878
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
Phase 2
Not yet recruiting
35 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NaSingle-groupOpen-labelOther
Summary
This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided individualized neoadjuvant therapy in patients with muscle-invasive bladder cancer who are candidates for radical cystectomy.
Timeline
- Start
- 2026-07
- Primary completion
- 2027-10
- Completion
- 2028-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Disitamab Vedotin | Monoclonal antibody | — | — |
| Subject | Enfortumab Vedotin | Other / unclassified | — | — |
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Toripalimab | Monoclonal antibody | — | — |